BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 31629156)

  • 1. Epithelial membrane antigen and DOG1 expression in minor salivary gland tumours.
    Andrade EP; Teixeira LN; Montalli VAM; Garcia FM; Passador-Santos F; Soares AB; Araújo VC
    Ann Diagn Pathol; 2019 Dec; 43():151408. PubMed ID: 31629156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of DOG-1 Expression in Salivary Gland Tumours and Comparison with Myoepithelial Markers.
    Khurram SA; Speight PM
    Head Neck Pathol; 2019 Jun; 13(2):140-148. PubMed ID: 29671211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of p63/p40 Expression With Myoepithelial Markers in Minor Salivary Gland Tumors.
    Teixeira LN; Janner ÉC; Teixeira T; Passador-Santos F; Martinez EF; Demasi APD; de Araújo NS; de Araújo VC
    Int J Surg Pathol; 2019 Jun; 27(4):360-371. PubMed ID: 30482064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The myoepithelial immunophenotype in 135 benign and malignant salivary gland tumors other than pleomorphic adenoma.
    Prasad AR; Savera AT; Gown AM; Zarbo RJ
    Arch Pathol Lab Med; 1999 Sep; 123(9):801-6. PubMed ID: 10458827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary gland-type tumors of the breast: a spectrum of benign and malignant tumors including "triple negative carcinomas" of low malignant potential.
    Foschini MP; Krausz T
    Semin Diagn Pathol; 2010 Feb; 27(1):77-90. PubMed ID: 20306833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic role of DOG1 and p63 immunohistochemistry in salivary gland carcinomas.
    Abd Raboh NM; Hakim SA
    Int J Clin Exp Pathol; 2015; 8(8):9214-22. PubMed ID: 26464669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of immunohistochemistry to the diagnosis of salivary gland tumors.
    de Araújo VC; de Sousa SO; Carvalho YR; de Araújo NS
    Appl Immunohistochem Mol Morphol; 2000 Sep; 8(3):195-202. PubMed ID: 10981871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human kallikrein 8 expression in salivary gland tumors.
    Darling MR; Tsai S; Jackson-Boeters L; Daley TD; Diamandis EP
    Head Neck Pathol; 2008 Sep; 2(3):169-74. PubMed ID: 20614312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twist Expression in Pleomorphic Adenoma, Adenoid Cystic Carcinoma and Mucoepidermoid Carcinoma of Salivary Glands.
    Pardis S; Zare R; Jaafari-Ashkavandi Z; Ashraf MJ; Khademi B
    Turk Patoloji Derg; 2016; 32(1):15-21. PubMed ID: 26832177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LEF-1: Diagnostic utility in distinguishing basaloid neoplasms of the salivary gland.
    Schmitt AC; Griffith CC; Cohen C; Siddiqui MT
    Diagn Cytopathol; 2017 Dec; 45(12):1078-1083. PubMed ID: 28972308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas.
    Edwards PC; Bhuiya T; Kelsch RD
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 May; 97(5):613-9. PubMed ID: 15153875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of runt-related transcription factor 3 associated with poor prognosis of adenoid cystic and mucoepidermoid carcinomas of the salivary gland.
    Sasahira T; Kurihara M; Yamamoto K; Bhawal UK; Kirita T; Kuniyasu H
    Cancer Sci; 2011 Feb; 102(2):492-7. PubMed ID: 21105967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Density of mast cells and microvessels in minor salivary gland tumors.
    Vidal MT; de Oliveira Araújo IB; Gurgel CA; Pereira Fde A; Vilas-Bôas DS; Ramos EA; Agra IM; Barros AC; Freitas VS; Dos Santos JN
    Tumour Biol; 2013 Feb; 34(1):309-16. PubMed ID: 23086574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wnt/β-catenin signal alteration and its diagnostic utility in basal cell adenoma and histologically similar tumors of the salivary gland.
    Sato M; Yamamoto H; Hatanaka Y; Nishijima T; Jiromaru R; Yasumatsu R; Taguchi K; Masuda M; Nakagawa T; Oda Y
    Pathol Res Pract; 2018 Apr; 214(4):586-592. PubMed ID: 29496310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Migration-stimulating factor as a novel biomarker in salivary gland tumours.
    Aljorani LE; Bankfalvi A; Carey FA; Harada K; Ohe G; Jones SJ; Ellis IR; Schor SL; Schor AM
    J Oral Pathol Med; 2011 Nov; 40(10):747-54. PubMed ID: 21481007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysozyme Expression Can be Useful to Distinguish Mammary Analog Secretory Carcinoma from Acinic Cell Carcinoma of Salivary Glands.
    Mariano FV; Gómez CA; de Souza do Nascimento J; Dos Santos HT; Egal ES; Montalli VA; Vargas PA; de Almeida OP; Altemani A
    Head Neck Pathol; 2016 Dec; 10(4):429-436. PubMed ID: 27177644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SOX10-positive salivary gland tumors: a growing list, including mammary analogue secretory carcinoma of the salivary gland, sialoblastoma, low-grade salivary duct carcinoma, basal cell adenoma/adenocarcinoma, and a subgroup of mucoepidermoid carcinoma.
    Hsieh MS; Lee YH; Chang YL
    Hum Pathol; 2016 Oct; 56():134-42. PubMed ID: 27327192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benign, malignant salivary gland tumors: comparison of immunohistochemical expression of e-cadherin.
    Prabhu S; Kaveri H; Rekha K
    Oral Oncol; 2009 Jul; 45(7):594-9. PubMed ID: 18955011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caveolin-1 overexpression in benign and malignant salivary gland tumors.
    Jaafari-Ashkavandi Z; Ashraf MJ; Nazhvani AD; Azizi Z
    Tumour Biol; 2016 Feb; 37(2):1863-9. PubMed ID: 26323261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent developments in the pathology of primary pulmonary salivary gland-type tumours.
    Naso JR; Roden AC
    Histopathology; 2024 Jan; 84(1):102-123. PubMed ID: 37694812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.